{"id":"W2133649749","doi":"10.1056/nejmoa035026","title":"Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America","year":2003,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":915,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Paul's Hospital; University of British Columbia","funders":"Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Enfuvirtide; Regimen; Medicine; Viral load; Internal medicine; Liter; Virology; Randomization; Drug resistance; Dolutegravir; Human immunodeficiency virus (HIV); Randomized controlled trial; Immunology; Gastroenterology; Antiretroviral therapy; Biology; Gp41; Microbiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005117994,0.0001805738,0.0005134963,0.0003737545,0.00006335629,0.000008945173,0.00003447577,0.0000458905,0.00006954792],"category_scores_gemma":[0.0003612177,0.0001155738,0.00005213144,0.0002595441,0.00006306687,0.0001112092,0.00000820479,0.0002231628,0.000003508049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009387914,"about_ca_system_score_gemma":0.0001999428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004242666,"about_ca_topic_score_gemma":0.0003523676,"domain_scores_codex":[0.9986228,0.00009212975,0.0005876838,0.0001689689,0.0003150511,0.0002133827],"domain_scores_gemma":[0.9989992,0.000127742,0.0002668288,0.0001116332,0.0001324353,0.0003621574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003022275,0.0003756815,0.9011937,0.0001131967,0.0001419227,0.0003573283,0.01240041,0.00002612407,0.002409268,0.0000923667,0.013293,0.06657468],"study_design_scores_gemma":[0.1873111,0.0044864,0.3828684,0.001369132,0.0007396122,0.001033106,0.002045126,0.000162393,0.001803461,0.0004240324,0.4173515,0.000405733],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918988,0.0007627833,0.0009580255,0.005325241,0.0002570626,0.000300223,0.000003461111,0.00001175605,0.0004825993],"genre_scores_gemma":[0.9931716,0.0006359919,0.002798583,0.0002395724,0.00105976,0.000005101692,0.00003226006,0.00002024907,0.002036921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5183253,"threshold_uncertainty_score":0.4712962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01274361375654826,"score_gpt":0.2547374387986145,"score_spread":0.2419938250420663,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}